1) Bauer KA, Eriksson BI, Lassen MR, et al:Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345:1305-1310, 2001
2) Eriksson BI, Bauer KA, Lassen MR, et al:Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective hip-fracture surgery. N Engl J Med 345:1298-1304, 2001
3) Eriksson BI, Lassen MR:Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery:a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 163:1337-1342, 2003
4) 冨士武史,藤田 悟:股関節骨折手術施行後の静脈血栓塞栓症の予防に対するFondaparinux Sodiumの有用性.骨折30:206-209,2008
5) Fuji T, Fujita S, Ochi T:Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop (SICOT) 32:443-451, 2008
6) Geerts WH, Pineo GF, Heit JA, et al:Prevention of venous thromboembolism:the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S-400S, 2004
7) 肺血栓塞栓症/深部静脈血栓症(静脈血栓塞栓症)予防ガイドライン作成委員会(編):肺血栓塞栓症/深部静脈血栓症(静脈血栓塞栓症)予防ガイドライン(第1版).Medical Front International Limited,東京,2004
8) 黒岩政之:日本麻酔科学会周術期肺血栓塞栓症調査結果からの知見・教訓.麻酔56:760-768,2007
9) 黒岩政之:日本における周術期肺血栓塞栓症の特徴,日本麻酔科学会周術期肺血栓塞栓症ワーキンググループの報告から.日本血栓止血学会誌 19:584,2008
10) Lassen MR, Bauer KA, Eriksson BI, et al:Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery:a randomised double-blind comparison. Lancet 359:1715-1720, 2002
11) 日本整形外科学会肺血栓塞栓症/深部静脈血栓症(静脈血栓塞栓症)予防ガイドライン改訂委員会(編):日本整形外科学会,静脈血栓塞栓症予防ガイドライン,南江堂,東京,2008
12) 菅野伸彦,津田晃佑,西井 孝・他:股関節手術に対する抗凝固剤を用いない静脈血栓塞栓症予防法.Hip Joint35:571-572,2009
13) Turpie AGG, Bauer KA, Eriksson BI, et al:Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery:a randomised double-blind trial. Lancet 359:1721-1726, 2002